Search British Patient Capital
Popular Search placeholder

British Patient Capital announces £25m commitment to 13books Capital’s latest Fund

Press release 17 July 2024

British Patient Capital has made a £25m commitment to 13books Capital’s latest fund. 13books Capital is a UK based, early-stage, venture capital fund manager, which will invest in early-stage fintech companies. British Patient Capital is joined by several other investors including KfW Capital, Isomer Capital and family office, IPGL. The fund has already made investments into five companies including UK based Lune.

13books Capital invests in fintech firms focussed on the biggest financial services sectors that are undergoing structural transformation as the industry becomes increasingly digitised. This opportunity includes the infrastructure and service layers of core fintech sectors, as well as the application of fintech to new markets.

The UK is home to an ecosystem of leading Fintech businesses, including a number of unicorns, and is a global leader in the sector. As investors in tomorrow’s financial technology, we are investing in 13books Capital’s latest fund as they look to support the new wave of innovative fintech businesses which will provide the technology that the financial services sector requires. The team at 13books Capital has the experience and sectoral expertise required to back bold founders and support early-stage fintech businesses as they look to scale. - Christine Hockley Managing Director, Funds, British Patient Capital
Continued innovation within financial services requires powerful technology. These innovative businesses not only need capital but supportive investors to help them scale, as well as the relevant expertise, network and talent. 13books Capital has those qualities and a history of investing in venture fintech and their latest fund will allow them to continue to provide this guidance to another generation of entrepreneurs. - Robert Greenwood Director, Funds, British Patient Capital
It is clear European fintech entrepreneurs desire a sector-focused, founder-led venture platform with impactful networks across the industry. We believe European fintech is entering a golden period, we thank our partners including British Patient Capital and founders for their trust and look forward to supporting the next generation of pioneering fintech entrepreneurs. - Steve Gibson Partner, 13books Capital

Further Information

Notes to editors

About British Patient Capital

British Patient Capital Limited is a wholly owned commercial subsidiary of British Business Bank plc, the UK government’s economic development bank. Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large-scale businesses. Launched in June 2018, British Patient Capital has more than £3bn of assets under management, investing in venture and venture growth capital to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. 

British Business Bank plc and its subsidiary entities are not banking institutions and do not operate as such. They are not authorised or regulated by the Prudential Regulation Authority (PRA) or the Financial Conduct Authority (FCA). A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc website.

British Patient Capital makes commitments and invests on its own behalf and on behalf of third-party investors whose investments British Patient Capital manages.

The transaction described above does not constitute or imply any endorsement, warranty or recommendation by the UK government, the British Business Bank plc, its subsidiaries or any other party in respect of 13books Capital or its products or services.

About 13books Capital

13books Capital invests in tomorrow’s financial technology with a mission to back Europe’s boldest and best fintech founders. Coupled with the experience and knowledge of its extensive network, 13books Capital supports the journey of fintech pioneers to realise their ambitions to scale globally.

Latest news